BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/4/2019 3:50:15 AM | Browse: 1622 | Download: 3083
Publication Name World Journal of Gastroenterology
Manuscript ID 46380
Country Germany
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis
Manuscript Source Unsolicited Manuscript
All Author List Peter Hoffmann, Cyrill Wehling, Johannes Krisam, Jan Pfeiffenberger, Nina Belling and Annika Gauss
ORCID
Author(s) ORCID Number
Peter Hoffmann http://orcid.org/0000-0002-5736-445X
Cyrill Wehling http://orcid.org/0000-0002-0584-3838
Johannes Krisam http://orcid.org/0000-0003-4092-7874
Jan Pfeiffenberger http://orcid.org/0000-0002-4741-3617
Nina Belling http://orcid.org/0000-0001-8481-0550
Annika Gauss http://orcid.org/0000-0001-8661-449X
Funding Agency and Grant Number
Corresponding Author Annika Gauss, MD, Assistant Professor, Doctor, Doctor, Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. annika.gauss@med.uni-heidelberg.de
Key Words Acute severe ulcerative colitis; Steroid-refractory; Tacrolimus; Rescue therapy; Calcineurin inhibitor; Inflammatory bowel disease; Hospitalized
Core Tip Steroid-refractory acute severe ulcerative colitis requires hospitalization and is frequently a risky tightrope walk between surgery and medical treatment. Whereas sufficient data has been provided over time to justify ciclosporin and infliximab as salvage therapies in this clinical scenario, guideline recommendations are still more reluctant towards tacrolimus due to the relative lack of data. However, tacrolimus may have advantages over ciclosporin especially due to its different toxicity profile. Our study provides more insight in the potential of tacrolimus in the strictly defined situation of steroid-refractory acute severe ulcerative colitis in hospitalized patients.
Publish Date 2019-04-04 03:01
Citation Hoffmann P, Wehling C, Krisam J, Pfeiffenberger J, Belling N, Gauss A. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. World J Gastroenterol 2019; 25(13): 1603-1617
URL https://www.wjgnet.com/1007-9327/full/v25/i13/1603.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i13.1603
Full Article (PDF) WJG-25-1603.pdf
Full Article (Word) WJG-25-1603.docx